Markets:

Overview

News

Currencies

International

Treasuries

Illumina, Inc. - Common Stock (NQ:ILMN)

146.99 +1.44 (+0.99%)

Streaming Delayed Price Updated: 4:00 PM EST, Jan 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Illumina, Inc. - Common Stock

< Previous 1 2

...

12 13 14 15 16 17 18 19 20

...

36 37 Next >

Myriad Genetics and Illumina Achieve Milestones in Strategic Partnership to Support Biopharma Clinical Trials

September 19, 2023

Myriad can conduct prospective clinical trials using Illumina’s TruSight Oncology Comprehensive Investigational Use Only test

From Myriad Genetics, Inc.

Via GlobeNewswire

Cramer Is 'Astonished' That Chewy Is 'Doing This Poorly — So Many Of Us Use It' ↗

September 14, 2023

On CNBC’s "Mad Money Lightning Round," Jim Cramer said yes to The St. Joe Company (NYSE: JOE). "I’ve liked St. Joe forever," he added.

Via Benzinga

AI Integration In Biotech & Pharma: Companies Positioned To Benefit ↗

September 11, 2023

The convergence of artificial intelligence (AI) with the biotech and pharmaceutical sectors is ushering in a new era of innovation. AI is catalyzing transformations from drug discovery to patient care....

Via Benzinga

Topics Artificial Intelligence

How Is The Market Feeling About Illumina? ↗

September 11, 2023

Via Benzinga

Is the Worst Over for Illumina Stock? ↗

September 09, 2023

There's reason to believe that the future is starting to look better.

Via The Motley Fool

$100 Invested In Illumina 20 Years Ago Would Be Worth This Much Today ↗

September 06, 2023

Via Benzinga

Did Elon Musk Admit 90% Decline In Twitter's Value Since Acquisition?, Apple's Zero-Click Vulnerabilities Uncovered By Internet Watchdog Group, Gas Prices Jump As Strikes Start At Major Chevron Australia LNG Projects: Today's Top Stories ↗

September 08, 2023

Benzinga

Via Benzinga

Billionaire Activist Investor Carl Icahn Shows Support For Illumina's Newly Appointed CEO ↗

September 08, 2023

Activist investor Carl Icahn has thrown his support behind Illumina Inc's (NASDAQ: ILMN) new CEO, Jacob Thaysen, providing a sigh of relief for the company as it strives to recover from a contentious...

Via Benzinga

Cathie Wood's Buying These 3 Stocks Hand Over Fist ↗

September 08, 2023

A drugmaker, a gene sequencer, and a streaming business all made deep impressions on Ark Invest's stock-picking team.

Via The Motley Fool

Why Is Illumina Stock Trading Lower Today? ↗

September 05, 2023

Illumina Inc (NASDAQ: ILMN) shares are trading lower after the company appointed Jacob Thaysen as its new CEO, roughly three months after the company parted ways

Via Benzinga

11 Analysts Have This to Say About Illumina ↗

September 01, 2023

Via Benzinga

Peering Into Illumina's Recent Short Interest ↗

August 18, 2023

Via Benzinga

Here's How Much You Would Have Made Owning Illumina Stock In The Last 20 Years ↗

August 17, 2023

Via Benzinga

Goldman Sachs Reveals Long-Term AI Portfolio: Here Are The 50 Stocks To Monitor ↗

August 22, 2023

Via Benzinga

Topics Artificial Intelligence

Wall Street Thinks Illumina Stock Will Rise 27% in 1 Year. Here's Why That Probably Won't Happen. ↗

August 21, 2023

Its core revenue won't grow, and that's not even its biggest problem at the moment.

Via The Motley Fool

Elliott Wave Technical Analysis: Illumina Inc. ↗

August 15, 2023

Looking for shorts with invalidation at $195.

Via Talk Markets

The Latest Analyst Ratings for Illumina ↗

August 14, 2023

Via Benzinga

Illumina Unusual Options Activity ↗

August 10, 2023

Via Benzinga

Down 15% in 2023, Should You Buy the Dip With Illumina Stock? ↗

August 17, 2023

Illumina's future is looking a bit dim at the moment.

Via The Motley Fool

Why Illumina Shares Are Falling Today ↗

August 11, 2023

Illumina Inc (NASDAQ: ILMN) disclosed in an SEC filing that the Securities and Exchange Commission is the latest government agency investigating the company's

Via Benzinga

Topics Regulatory Compliance

Illumina To Bear The Brunt Of Slowdown In Consumables Purchasing Amid Lower Demand In China: Analyst ↗

August 10, 2023

Stifel analyst Daniel Arias reiterated a Buy rating on Illumina, Inc (NASDAQ: ILMN),

Via Benzinga

Alibaba, Illumina, CyberArk Software And Other Big Stocks Moving Higher On Thursday ↗

August 10, 2023

U.S. stocks traded higher, with the Dow Jones gaining around 350 points on Thursday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Topics Stocks

(ILMN) - Analyzing Illumina's Short Interest ↗

August 02, 2023

Via Benzinga

Nasdaq, S&P 500 Futures Rally Ahead Of Inflation Data; Why This Analyst Sounds Out Caution About Stock Valuations ↗

August 10, 2023

Via Benzinga

Topics Economy Stocks

Disney, Alibaba And 3 Stocks To Watch Heading Into Thursday ↗

August 10, 2023

With U.S. stock futures trading higher this morning on Thursday, some of the stocks that may grab investor focus today are as follows:

Via Benzinga

Illumina Stock Crumbles As Earnings Guidance Completely Misses Forecasts ↗

August 09, 2023

Illumina beat second-quarter expectations, but earnings guidance completely missed.

Via Investor's Business Daily

US Stocks Walk Inflation Tightrope As Futures Point To Cautious Recovery: Why This Analyst Downplays Fed Rate Worries ↗

August 09, 2023

Stocks could recover on Wednesday from Thursday's weakness, spearheaded by tech and financial stocks, but traders could show restraint.

Via Benzinga

BNGO Stock Alert: Bionano Just Reverse Split Its Stock ↗

August 07, 2023

Bionano was a hot genetic analysis stock two years ago but now needed a reverse split so that BNGO stock could stay listed on the Nasdaq.

Via InvestorPlace

Week In Review: Pyrotech Closes $97 Million Series A Round For Immunomodulator Drugs ↗

July 29, 2023

Beijing’s Pyrotech Therapeutics completed a $97 million Series A funding to develop novel small molecule drugs that modulate immune responses for autoimmune diseases. Meanwhile, Mirxes Holding closed a...

Via Talk Markets

Biotech Battlefields: 3 Stocks to Watch Amid Wall Street Turmoil ↗

July 29, 2023

There is opportunity in a crisis. Key biotech stocks amid turmoil could be the greatest deals on the market today.

Via InvestorPlace

< Previous 1 2

...

12 13 14 15 16 17 18 19 20

...

36 37 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.